transient tachypnea of the newborn. Respiratory distress of newborn
Conditions
Interventions
Intervention 1: In the control group, in the first day of life 60ml/kg/d, in the second day 80ml/kg/d and from the third day 100 ml/kg/d of 10% dextrose water were administered. In cases who were care
Treatment - Other
In the control group, in the first day of life 60ml/kg/d, in the second day 80ml/kg/d and from the third day 100 ml/kg/d of 10% dextrose water were administered. In cases who were cared under radiant
In the intervention group, in the first day of life 40ml/kg/d, in the second day 60ml/kg/d and from the third day 80 ml/kg/d of 10% dextrose water were administered. In cases who were cared under radi
Sponsors
Ahvaz,Jundishapur University of Medical Siences
Eligibility
Sex/Gender
All
Age
No minimum to 1 Years
Inclusion criteria
Inclusion criteria: inclusion criteria: neonate with in 34-0/7to 41-6/7 weeks age with: tachypnoea (RR>60) ;standing on tachypnea at least for 12 hrs; feature of CXR at least for one of these: prominent pulmonary hilus, increase thickness of lobar fisher due to accumulation of fluid, hilar congestion of both lung,flattening of diaphragm,increase AP diameter of chest exclusion criteria:neonate with congenital anomaly;systemic sepsis; mecunium aspiration; RDS; IUGR; fetal distress history; pneomonitis;congenital heart disease; DIC; multi organ failure; hypocalcemia; hypoglycemia; polycytemia; Na>150; Bun>20; K>5; Bill>15; urine out put<1cc/kg/hr
Exclusion criteria
Exclusion criteria:
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Duration of oxygen requirement. Timepoint: during intervention. Method of measurement: hours.;Duration of CPAP requirement. Timepoint: during intervention. Method of measurement: hours.;Duration of VENTILATOR requirement. Timepoint: during intervention. Method of measurement: hours.;Hospitalized duration. Timepoint: during intervention. Method of measurement: days. | — |
Secondary
| Measure | Time frame |
|---|---|
| Urine out put. Timepoint: during intervention. Method of measurement: cc/kg/hr.;Serum BUN , CREATININ. Timepoint: during intervention. Method of measurement: serum sampling.;Serum K , Na. Timepoint: during intervention. Method of measurement: serum sampling.;Serum bilirubin. Timepoint: during intervention. Method of measurement: serum sampling.;Specific gravity of urine. Timepoint: during intervention. Method of measurement: with refractometer.;ABG. Timepoint: during intervention. Method of measurement: artery sampling. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactMasud Dehdashtian MD.
Ahvaz,JundishapurUniversity of medical Sciences
Outcome results
None listed